Evaluation of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Postmenopausal Women

Sponsor
Secretaria Municipal de Saúde de Rolante (Other)
Overall Status
Unknown status
CT.gov ID
NCT03032185
Collaborator
Centro Universitario La Salle (Other)
30
1
2
5.9
5

Study Details

Study Description

Brief Summary

Introduction: Menopause is the last menstrual period, it is a natural phenomenon to all women. Postmenopausal, some women may experience unpleasant symptoms such as hot flushes, urogenital pain, headache and pains in the musculoskeletal system. That happens due to the decreased ovarian hormone secretion and changes in the autonomic system. Pain is also caused by a complex autonomic activity. For pain management, a therapeutic electrical stimulation of the peripheral nervous system promotes modulation of nociceptive incentives and release of endogenous opioids. According to reviewed studies, the use of transcutaneous electrical nerve stimulation (TENS), by directly stimulating the central nervous system, has presented results of manipulation of the autonomic system, being observed change in heart rate and cognitive improvement in dementia. Given this possibility, the present study aims to investigate whether the use of Transcutaneous Electrical Nerve Stimulation in low frequency can generate autonomic and psychophysical changes in healthy postmenopausal women.

Objective: To evaluate the effectiveness of Transcutaneous Electrical Nerve Stimulation on autonomic and psychophysical parameters in postmenopausal women.

Methods: randomized, crossover, double-blind. A sample of thirty patients will be selected according to inclusion and exclusion criteria previously established. The autonomic and psychophysical functions will be evaluated by Quantitative Sensory Testing and Conditioned Pain Modulation (pain thresholds to heat and modulation of conditioned pain, respectively), as well as scales to evaluate catastrophism and sleep quality (by scale of Pittsburgh Sleep Quality Index). After application of the scales, the participants will be subject to active Ttranscutaneous Electrical Nerve Stimulation session or sham with a fortnight washout as randomization. All the research subjects will be invited to participate in the study and sign an Informed Consent and Informed (ICI). This study will be registered in the Clinical Trials.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcutaneous Elevtrical Nerve Stimulation
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Evaluation of Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Autonomic and Psychophysical Parameters in Postmenopausal Women
Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active TENS

Active TENS, 10 Hz/200 μs

Device: Transcutaneous Elevtrical Nerve Stimulation
Other Names:
  • Transcutaneous Electrical Nerve Stimulation
  • Sham Comparator: Not Active TENS

    Sham TENS

    Device: Transcutaneous Elevtrical Nerve Stimulation
    Other Names:
  • Transcutaneous Electrical Nerve Stimulation
  • Outcome Measures

    Primary Outcome Measures

    1. Autonomic changes in postmenopausal women's health [30 days]

      Heart rate's modification tested by R-R interval on electrocardiogram.

    2. Psychophysical changes in postmenopausal women´s health [30 days]

      pain evaluated by Quality Sensitive Test

    Secondary Outcome Measures

    1. Descendent Inibitory System Pain changes in postmenopausal women´s health [30 days]

      evaluated by conditioned pain modulated test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 65 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • To be in the period of post-menopause;

    • Do not have chronic diseases or comorbidities in drug treatment;

    • Accept to participate in the study and sign the free and informed consent form.

    Exclusion Criteria:
    • Start continuous medication during the study period;

    • Display cognitive problems that make it difficult to understand the questionnaires and proposals;

    • History of alcohol or drug abuse in the last 6 months;

    • History of neurological disorders;

    • History of cardiac arrhythmias;

    • History of moderate or severe head injury;

    • History of neurosurgery;

    • Uncompensated systemic diseases, and chronic inflammatory diseases (diabetes, lupus, rheumatoid arthritis, Sjogren's syndrome, Reiter's syndrome);

    • History of uncompensated hypothyroidism;

    • History of personal cancer, past or treatment.

    • Wish referred to leave the study at any time.

    • No attendance to the stages that make up the research.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Andressa de Souza Canoas Rio Grande do Sul Brazil

    Sponsors and Collaborators

    • Secretaria Municipal de Saúde de Rolante
    • Centro Universitario La Salle

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lucélia Caroline dos santos Cardoso, Master of Science, Secretaria Municipal de Saúde de Rolante
    ClinicalTrials.gov Identifier:
    NCT03032185
    Other Study ID Numbers:
    • 48302915.1.0000.5307
    First Posted:
    Jan 26, 2017
    Last Update Posted:
    Jan 26, 2017
    Last Verified:
    Jan 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Lucélia Caroline dos santos Cardoso, Master of Science, Secretaria Municipal de Saúde de Rolante

    Study Results

    No Results Posted as of Jan 26, 2017